BioSpace News Archive

LEXEO Therapeutics (LEXEO), a clinical-stage gene therapy company advancing a deep and diverse pipeline of adeno-associated virus (AAV)-based gene therapy candidates for genetically defined cardiovascular and central nervous system (CNS) diseases, announced today that R. Nolan Townsend, Chief Executive Officer of LEXEO, will participate in the following upcoming investor conferences.

Crinetics Pharmaceuticals, Inc today announced the appointment of Chris Robillard to the newly created position of chief business officer.

Vera Therapeutics, Inc. today announced that it will host a key opinion leader (KOL) webinar discussing BK Virus (BKV) featuring world-renowned transplant nephrologist and pioneering kidney transplant researcher, Stanley C. Jordan, M.D., FASN, FAST.

Primmune Therapeutics Presents Data Evaluating PRTX007 as an Antiviral at the 35th International Conference on Antiviral Research (ICAR).

BRAINBox Solutions, Inc. today announced that the company, in collaboration with leading institutions, including Carilion Clinic and the Virginia Tech Carilion (VTC) School of Medicine, has been notified that they have been awarded a $3.5 million SBIR grant from the National Institute of Neurological Disorders and Stroke.

On the heels of Integrated DNA Technologies’ xGen™ NGS portfolio launch in December, MLL, the Munich Leukemia Laboratory, one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions provider’s Align Program.

Taconic Biosciences has appointed Nomura Siam International Co., Ltd. (NSI) and Nomura Jimusho. Inc. (NJI) as sales agents and distributors of the rasH2 Mouse Carcinogenicity Test System in India and China, respectively.

Vivacitas Oncology, Inc. is honored to welcome, Dr. David Reardon, MD, Professor of Medicine at Harvard Medical School and Clinical Director for Dana-Farber Cancer Institute, Center for Neuro-Oncology as a new member of its top-tier Neuro-Oncology Advisory Board.

Noblis, Inc., a leading provider of science, technology and strategy services to the federal government, announced the award of U.S. patent 11,222,712 for primer design using indexed genomic information.

RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, launched , debuting technology that enables unprecedented access to long synthetic genes and their functional readouts with multiple applications.